MBL Wealth LLC Sells 2,327 Shares of Oracle Corporation $ORCL

Key Points

• MBL Wealth LLC has reduced its stake in Oracle Corporation by 22.7%, selling 2,327 shares and now holding 7,912 shares valued at approximately $1.73 million.
• Insider Clayton M. Magouyrk sold over 21,000 shares, marking a 21.40% decrease in his position, while other insiders collectively sold 104,314 shares in the last ninety days.
• Wall Street analysts have set various price targets for Oracle, with an average rating of "Moderate Buy" and a target price of approximately $304.71.

MBL Wealth LLC reduced its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 22.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,912 shares of the enterprise software provider's stock after selling 2,327 shares during the period. MBL Wealth LLC's holdings in Oracle were worth $1,730,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Redmont Wealth Advisors LLC bought a new stake in shares of Oracle in the 1st quarter worth about $27,000. Inlight Wealth Management LLC bought a new position in Oracle during the 1st quarter valued at about $28,000. Iron Horse Wealth Management LLC boosted its position in Oracle by 284.9% in the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock valued at $29,000 after buying an additional 151 shares during the period. Legend Financial Advisors Inc. purchased a new stake in Oracle in the 2nd quarter valued at about $34,000. Finally, HighMark Wealth Management LLC bought a new stake in shares of Oracle in the 2nd quarter valued at about $38,000. 42.44% of the stock is currently owned by institutional investors.

Insider Activity at Oracle

In other news, insider Clayton M. Magouyrk sold 21,241 shares of the business's stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the sale, the insider owned 78,000 shares in the company, valued at approximately $23,174,580. The trade was a 21.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Naomi O. Seligman sold 3,303 shares of the business's stock in a transaction that occurred on Wednesday, July 16th. The stock was sold at an average price of $233.32, for a total transaction of $770,655.96. Following the sale, the director owned 31,447 shares of the company's stock, valued at $7,337,214.04. This represents a 9.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 104,314 shares of company stock worth $31,272,223 over the last ninety days. 42.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ORCL has been the subject of several recent analyst reports. Sanford C. Bernstein boosted their price objective on shares of Oracle from $363.00 to $364.00 and gave the stock an "outperform" rating in a research note on Friday, September 26th. Guggenheim increased their price target on shares of Oracle from $250.00 to $375.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. BMO Capital Markets set a $345.00 price target on shares of Oracle in a research note on Wednesday, September 10th. The Goldman Sachs Group raised their price target on shares of Oracle from $195.00 to $310.00 and gave the stock a "neutral" rating in a research note on Monday, September 15th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $342.00 target price on shares of Oracle in a research note on Wednesday, September 24th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Oracle presently has an average rating of "Moderate Buy" and an average target price of $304.71.

Oracle Trading Down 0.9%

Shares of ORCL stock opened at $286.23 on Friday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The stock has a market capitalization of $815.99 billion, a P/E ratio of 66.26, a price-to-earnings-growth ratio of 3.08 and a beta of 1.53. The company has a 50 day moving average price of $262.53 and a 200 day moving average price of $205.48. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72.

Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. During the same quarter last year, the firm posted $1.39 EPS. The company's revenue for the quarter was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts predict that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle's payout ratio is 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.